🇺🇸 FDA
Patent

US 11414423

Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders

granted A61PA61P25/28A61P25/32

Quick answer

US patent 11414423 (Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders) held by The Regents of the University of California expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P25/28, A61P25/32